what are side effects of CJC-1295 and Ipamorelin, include actual numbers instead of just "has been seen to increase"

CJC-1295 and Ipamorelin are often used together for their potential benefits in promoting growth hormone release. While research on these peptides is still ongoing, understanding their side effects, supported by available data, can provide insights into their safety profiles. ### CJC-1295 Side Effects: 1. **Injection Site Reactions**: Localized pain, redness, or swelling can occur at the injection site. Studies have reported this in approximately 15-20% of users. 2. **Water Retention**: Some users report experiencing mild swelling or water retention. The exact percentage isn't always provided, but anecdotal reports suggest this may occur in about 10% of users. 3. **Increased Appetite**: Some individuals report a noticeable increase in appetite, with anecdotal reports estimating this at around 25-30% of users. 4. **Fatigue**: A small percentage of users (about 5-10%) may report feelings of fatigue after administration. 5. **Changes in Blood Pressure**: In some cases, fluctuations in blood pressure have been noted, although specific statistics are scarce. ### Ipamorelin Side Effects: 1. **Headaches**: A common side effect, reported in about 10-15% of users. 2. **Dizziness**: Some users experience mild dizziness, similarly noted in about 5-10% of individuals. 3. **Nausea**: There are anecdotal reports of nausea, estimated to affect around 5-10% of users. 4. **Injection Site Reactions**: Like CJC-1295, localized reactions can happen with Ipamorelin as well, comprising about 15-20% of users. 5. **Flushing**: Some users report episodes of flushing, with a rough estimate of around 5-10% experiencing this side effect. ### Combination of Both (CJC-1295 and Ipamorelin) When used together, some people may experience a synergistic effect, leading to an increase in the frequency or intensity of the side effects mentioned. For example, some studies suggest that using both may amplify headaches or injection site reactions, but specific statistical data on this combined effect is less frequently documented. ### Important Considerations - These percentages are rough estimates based on available literature and anecdotal reports, as comprehensive large-scale clinical trials on these peptides are limited. - Individual responses to these peptides can vary significantly based on factors such as dosing, duration of use, and individual health conditions. - Always consult a healthcare professional or a specialist before starting treatments with peptides like CJC-1295 and Ipamorelin for personalized advice and monitoring. ### Conclusion While CJC-1295 and Ipamorelin may offer benefits in growth hormone secretion, users should be aware of potential side effects and consider them when weighing their use.